About Alimera Sciences
Alimera Sciences is a company based in Alpharetta (United States) founded in 2003 was acquired by ANI Pharmaceuticals in July 2024. It operates as a Reseller / Distribution. Alimera Sciences has raised $66.8 million across 9 funding rounds from investors including ANI Pharmaceuticals, SLR Investment Corp and Lincoln Park Capital. The company has 79 employees as of December 31, 2022. Alimera Sciences offers products and services including Ophthalmic Products. Alimera Sciences operates in a competitive market with competitors including Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others.
- Headquarter Alpharetta, United States
- Employees 79 as on 31 Dec, 2022
- Stage Public
-
Sectors
Healthcare
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Alimera Sciences Europe Ltd
-
Annual Revenue
$80.75 M49as on Dec 31, 2023
-
Net Profit
$-20.13 M-11as on Dec 31, 2023
-
EBITDA
$6.82 M176as on Dec 31, 2023
-
Total Equity Funding
$66.8 M (USD)
in 9 rounds
-
Latest Funding Round
$81 M (USD), Post-IPO
May 31, 2023
-
Investors
ANI Pharmaceuticals
& 7 more
-
Employee Count
79
as on Dec 31, 2022
-
Acquired by
ANI Pharmaceuticals
(Jul 17, 2024)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of Alimera Sciences
Alimera Sciences offers a comprehensive portfolio of products and services, including Ophthalmic Products. The company's diverse product and service offerings are designed to meet the evolving needs of its customers, address market demands, and provide comprehensive solutions that drive value creation and customer satisfaction across various segments and use cases.
Products for eye conditions are developed and distributed.
Unlock access to complete
Funding Insights of Alimera Sciences
Alimera Sciences has successfully raised a total of $66.8M across 9 strategic funding rounds. The most recent funding activity was a Post-IPO round of $81 million completed in May 2023. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 9
- Last Round Post-IPO — $81.0M
-
First Round
First Round
(30 Nov 2005)
- Investors Count 7
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| May, 2023 | Amount | Post-IPO - Alimera Sciences | Valuation |
investors |
|
| Oct, 2019 | Amount | Post-IPO - Alimera Sciences | Valuation |
investors |
|
| Jan, 2018 | Amount | Debt – Conventional - Alimera Sciences | Valuation |
investors |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Alimera Sciences
Alimera Sciences has secured backing from 8 investors, including venture fund investors. Prominent investors backing the company include ANI Pharmaceuticals, SLR Investment Corp and Lincoln Park Capital. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Private equity investments are directed toward North American opportunities.
|
Founded Year | Domain | Location | |
|
Debt and equity investments are offered by the firm.
|
Founded Year | Domain | Location | |
|
US focused venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Alimera Sciences
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Alimera Sciences
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Alimera Sciences Comparisons
Competitors of Alimera Sciences
Alimera Sciences operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Kriya Therapeutics, Annexon, Aldeyra, Nicox and Gyroscope, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Developer of therapeutic solutions for the treatment of diabetes
|
|
| domain | founded_year | HQ Location |
Developer of antibodies to treat complement-mediated neurodegenerative diseases
|
|
| domain | founded_year | HQ Location |
Drug candidates for immune-mediated diseases are developed by Aldeyra.
|
|
| domain | founded_year | HQ Location |
Nitric oxide-based therapeutics for glaucoma and eye conditions are developed.
|
|
| domain | founded_year | HQ Location |
Mobile SDK developed for app engagement and monetization strategies.
|
|
| domain | founded_year | HQ Location |
Gene therapies for ocular and neurodegenerative diseases are developed.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Alimera Sciences
Frequently Asked Questions about Alimera Sciences
When was Alimera Sciences founded?
Alimera Sciences was founded in 2003 and raised its 1st funding round 2 years after it was founded.
Where is Alimera Sciences located?
Alimera Sciences is headquartered in Alpharetta, United States. It is registered at Alpharetta, Georgia, United States.
Is Alimera Sciences a funded company?
Alimera Sciences is a funded company, having raised a total of $66.8M across 9 funding rounds to date. The company's 1st funding round was a Debt – Conventional of $40M, raised on Nov 30, 2005.
How many employees does Alimera Sciences have?
As of Dec 31, 2022, the latest employee count at Alimera Sciences is 79.
What is the annual revenue of Alimera Sciences?
Annual revenue of Alimera Sciences is $80.75M as on Dec 31, 2023.
What does Alimera Sciences do?
Alimera Sciences is involved in the distribution of ophthalmic pharmaceutical products across Europe, the Middle East, and Africa. The company collaborates with a network of distribution partners to provide solutions for eye-related conditions. Operations are focused on ensuring access to specialized treatments in various countries within these regions.
Who are the top competitors of Alimera Sciences?
What products or services does Alimera Sciences offer?
Alimera Sciences offers Ophthalmic Products.
Who are Alimera Sciences's investors?
Alimera Sciences has 8 investors. Key investors include ANI Pharmaceuticals, SLR Investment Corp, Lincoln Park Capital, Polaris Partners, and Intersouth Partners.